^
Chr amplification(11)(q13)
|
Nasopharyngeal Carcinoma
|
Chr amplification(11)(q13)
|
Nasopharyngeal Carcinoma
|
toripalimab Resistant: C3 – Early Trials
|
toripalimab Resistant: C3 – Early Trials
|
Chr amplification(11)(q13)
|
Gastric Adenocarcinoma
|
Chr amplification(11)(q13)
|
Gastric Adenocarcinoma
|
Immunotherapy Resistant: C3 – Early Trials
|
Immunotherapy Resistant: C3 – Early Trials
|
